Mindfulness in ovarian cancer

Completed

• Conditions: Specialty: Cancer, Primary sub-specialty: Gynaecological Cancers; UKCRC code/ Disease: Cancer/ Malignant neoplasms of female genital organs; Cancer; Ovarian cancer

• Registration Number: ISRCTN95243663
• Lead Sponsor: Portsmouth Hospitals NHS Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-12-05
• Study Completion: 2017-05-09
• Last Update Posted: 12 February 2018

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

1. Any confirmed recurrence of OvCa at any stage
2. Aged 18 years and above
3. Willing to participate and provide informed consent
4. Fluent English (questionnaires validated and interviews conducted in English); 1. Any confirmed recurrence of OvCa at any stage
2. Aged 18 years and above
3. Willing to participate and provide informed consent
4. Fluent English (questionnaires validated and interviews conducted in English)

Exclusion Criteria

1. Additional cancer diagnoses
2. Any significant mental illness (i.e. overt psychosis, history of suicidal ideation) but not to include clinical depression and/or anxiety
3. Receiving any other psychological therapy; 1. Additional cancer diagnoses
2. Any significant mental illness (i.e. overt psychosis, history of suicidal ideation) but not to include clinical depression and/or anxiety
3. Receiving any other psychological therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility outcomes:<br>1. Recruitment rate<br>2. Response rates<br>3. Number of patients completing the intervention <br>4. Number of patients completing the 6 month follow-up<br>5. Qualitative assessment of the intervention <br>6. Quantitative data analysis;Feasibility outcomes:<br>1. Recruitment rate<br>2. Response rates<br>3. Number of patients completing the intervention <br>4. Number of patients completing the 6 month follow-up<br>5. Qualitative assessment of the intervention <br>6. Quantitative data analysis

Secondary Outcome Measures

Name	Time	Method
1. Anxiety<br>2. Depression<br>3. Quality of life<br>4. Diurnal cortisol variations;1. Anxiety<br>2. Depression<br>3. Quality of life<br>4. Diurnal cortisol variations